Bleakley Financial Group’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7M Buy
43,112
+745
+2% +$226K 0.24% 80
2026
Q1
$9.05M Buy
42,367
+4,678
+12% +$1.05M 0.14% 116
2025
Q4
$6.45M Buy
37,689
+3,396
+10% +$528K 0.11% 155
2025
Q3
$4.59M Sell
34,293
-774
-2% -$82K 0.11% 166
2025
Q2
$3.41M Buy
35,067
+7,549
+27% +$599K 0.09% 198
2025
Q1
$2M Buy
27,518
+2,922
+12% +$230K 0.06% 243
2024
Q4
$1.78M Sell
24,596
-904
-4% -$68.6K 0.05% 274
2024
Q3
$2.08M Sell
25,500
-4,090
-14% -$356K 0.06% 248
2024
Q2
$3.15M Sell
29,590
-80
-0.3% -$7.67K 0.09% 200
2024
Q1
$2.88M Buy
29,670
+1,180
+4% +$104K 0.08% 229
2023
Q4
$2.23M Buy
28,490
+4,070
+17% +$277K 0.07% 259
2023
Q3
$1.53M Sell
24,420
-1,780
-7% -$117K 0.05% 304
2023
Q2
$1.68M Sell
26,200
-30
-0.1% -$1.69K 0.05% 306
2023
Q1
$1.39M Buy
26,230
+1,470
+6% +$72.1K 0.05% 327
2022
Q4
$1.04M Buy
+24,760
New +$1.04M 0.04% 366

Other funds holding LRCX

Bleakley Financial Group's LRCX Position: Q2 2026 in Review

Bleakley Financial Group increased its Lam Research (LRCX) stake by 1.8% in Q2 2026, buying an estimated $226K and bringing the position to 43,112 shares worth $18.7M. The position accounts for 0.24% of the portfolio, ranked #80.

Bleakley Financial Group first reported a position in LRCX in Q4 2022 and has held it in 15 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Bleakley Financial Group held 43,112 shares of Lam Research worth $18.7M as of Q2 2026.
  • Bleakley Financial Group bought 745 Lam Research shares in Q2 2026, an estimated $226K.
  • Lam Research made up 0.24% of Bleakley Financial Group's portfolio in Q2 2026, its #80 holding.
  • Bleakley Financial Group first reported a position in Lam Research in Q4 2022 and has held it in 15 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.